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Assessment of the worldwide burden of critical illness: 
the Intensive Care Over Nations (ICON) audit
Jean-Louis Vincent, John C Marshall, Silvio A Ñamendys-Silva, Bruno FranÇois, Ignacio Martin-Loeches, Jeff rey Lipman, Konrad Reinhart, 
Massimo Antonelli, Peter Pickkers, Hassane Njimi, Edgar Jimenez, Yasser Sakr, on behalf of the ICON investigators*
Summary
Background Global epidemiological data regarding outcomes for patients in intensive care units (ICUs) are scarce, 
but are important in understanding the worldwide burden of critical illness. We, therefore, did an international audit 
of ICU patients worldwide and assessed variations between hospitals and countries in terms of ICU mortality.
Methods 730 participating centres in 84 countries prospectively collected data on all adult (>16 years) patients admitted to 
their ICU between May 8 and May 18, 2012, except those admitted for fewer than 24 h for routine postoperative 
monitoring. Participation was voluntary. Data were collected daily for a maximum of 28 days in the ICU and patients 
were followed up for outcome data until death or hospital discharge. In-hospital death was analysed using multilevel 
logistic regression with three levels: patient, hospital, and country.
Findings 10 069 patients were included from ICUs in Europe (5445 patients; 54·1%), Asia (1928; 19·2%), the 
Americas (1723; 17·1%), Oceania (439; 4·4%), the Middle East (393; 3·9%), and Africa (141; 1·4%). Overall, 
2973 patients (29·5%) had sepsis on admission or during the ICU stay. ICU mortality rates were 16·2% (95% CI 
15·5–16·9) across the whole population and 25·8% (24·2–27·4) in patients with sepsis. Hospital mortality rates were 
22·4% (21·6–23·2) in the whole population and 35·3% (33·5–37·1) in patients with sepsis. Using a multilevel 
analysis, the unconditional model suggested signifi cant between-country variations (var=0·19, p=0·002) and between-
hospital variations (var=0·43, p<0·0001) in the individual risk of in-hospital death. There was a stepwise increase in 
the adjusted risk of in-hospital death according to decrease in global national income.
Interpretation This large database highlights that sepsis remains a major health problem worldwide, associated with 
high mortality rates in all countries. Our fi ndings also show a signifi cant association between the risk of death and the 
global national income and suggest that ICU organisation has an important eff ect on risk of death.
Funding None.
Introduction
Intensive care medicine has grown substantially over the 
past decades and now consumes a substantial part of the 
income of many countries worldwide (close to 1% of the 
gross domestic product [GDP] in the USA1). Previous 
studies have provided some epidemiological data regarding 
types of patients and treatments used in intensive care 
units (ICUs) and outcomes for patients in ICUs at a local 
and a national level, but there is much less information 
available at an international level.2 A review in 2010 
stressed that there is a “need to measure the global burden 
of critical illness and available critical-care resources, and 
develop both preventive and therapeutic interventions that 
are generalisable across countries”.2 The World Federation 
of Societies of Intensive and Critical Care Medicine, with a 
membership of more than 70 national societies of intensive 
and critical care medi cine, provided a unique platform to 
initiate an audit of data from ICUs around the world to 
develop an international picture of the types of critically 
ill patients admitted to our ICUs, with a special 
emphasis on sepsis and organ failure. We provide a 
summary of the key fi ndings of this major worldwide 
collaborative initiative, providing important insights 
into characteristics of intensive care patient populations 
and variations in mortality rates between diff erent 
countries and regions of the globe.
Methods
Participating centres 
Recruitment for participation in the Intensive Care Over 
Nations (ICON) audit was by open invitation, through 
national scientifi c societies, national and international 
meetings, and individual contacts. Participation was 
entirely voluntary, with no fi nancial incentive. Institutional 
review board approval was obtained by the participating 
institutions in accordance with local ethical regulations.
Each participating centre (appendix) was asked to 
prospectively collect data on all adult patients (>16 years) 
admitted to their ICU between May 8 and May 18, 2012, 
except those who stayed in the ICU for fewer than 24 h for 
routine postoperative surveillance. Readmissions of 
previously included patients were excluded. Data were 
collected daily during the ICU stay for a maximum of 
28 days. Patients were followed up for outcome data until 
death or hospital discharge.
Case report forms (CRFs; appendix) were electronically 
provided by the investigators using a secured internet-
based website. Data collection on admission included 






See Comment page 343
*Details of ICON investigators 
are given in the appendix
Department of Intensive Care, 
Erasme University Hospital, 
Université Libre de Bruxelles, 
Brussels, Belgium 
(Prof J-L Vincent MD, 
H Njimi PhD); Department of 
Surgery, Interdepartmental 
Division of Critical Care 
Medicine, University of Toronto, 
St Michael’s Hospital, Toronto, 
ON, Canada 
(Prof J C Marshall MD); 
Department of Critical Care 
Medicine, Instituto Nacional 
de Cancerología, Mexico City, 
Mexico 
(S A Ñamendys-Silva MD); Service 
de Réanimation Polyvalente, 
CHU Dupuytren, Limoges cedex, 
France (Prof B François MD); 
Critical Care Centre, Corporació 
Sanitària I Universitaria Parc 
Taulí—Hospital De Sabadell, 
Institut Universitari Uab, Ciber 
Enfermedades Respiratorias, 
Sabadell, Barcelona, Spain 
(I Martin-Loeches MD); 
Department of Intensive Care 
Medicine, Royal Brisbane and 
Women’s Hospital, University of 
Queensland, QLD, Australia 
(Prof J Lipman MD); Department 
of Anaesthesiology and 
Intensive Care and Centre for 
Sepsis Care and Control, Jena 
University Hospital, Jena, 
Germany (Prof K Reinhart MD, 
Y Sakr MD); Department of 
Anaesthesiology and Intensive 
Care, Catholic University—
Policlinico A Gemelli University 
Hospital, Rome, Italy 
(Prof M Antonelli MD); 
Department of Intensive Care, 
Nijmegen Institute for 
Infection, Infl ammation and 
Immunity, Radboud University 
Nijmegen Medical Centre, 
Nijmegen, Netherlands 
(P Pickkers MD); and Department 
of Critical Care, Orlando 
Articles
www.thelancet.com/respiratory   Vol 2   May 2014 381
Regional Medical Center, 
Orlando, FL, USA (E Jimenez MD)
Correspondence to:
Prof Jean-Louis Vincent, 
Department of Intensive Care, 
Erasme Hospital, 
Route de Lennik 808, 1070, 
Brussels
jlvincen@ulb.ac.be
See Online for appendix
demographic data and comorbid diseases. Clinical and 
laboratory data for simplifi ed acute physiology score 
(SAPS) II3 and acute physiology and chronic health 
evaluation (APACHE) II4 scores were reported as the worst 
values within 24 h after admission. Microbiological and 
clinical infections were reported daily as well as the 
antibiotics given. A daily assessment of organ function in 
accordance with the sequential organ failure assessment 
(SOFA) score5 was done.
Defi nitions
Infection was defi ned in accordance with the defi nitions 
of the International Sepsis Forum.6 Sepsis was defi ned as 
the presence of infection with the concomitant 
occurrence of at least one organ failure (defi ned as a 
SOFA score >2 for the organ in question).7 Septic shock 
was defi ned as sepsis associated with cardiovascular 
failure (defi ned as a cardiovascular SOFA score >2).7
Surgical admissions referred to patients who had had 
surgery in the 4 weeks preceding admission. The 
presence of several comorbid disorders3,4 was noted: 
chronic obstructive pulmonary disease (COPD), 
metastatic cancer (metastases proven by surgery, CT or 
MRI, or any other method), liver cirrhosis, heart failure 
(New York Heart Association classifi cation [NYHA] 
III/IV), haematological malignancy (lymphoma, acute 
leukaemia, or multiple myeloma), acquired immuno-
defi ciency syndrome, chronic renal failure (need for 
chronic renal support or history of chronic renal 
insuffi  ciency with a serum creatinine greater than 
3·6 mg/dL [300 μmol/L]5), immunosuppression (steroid 
treatment given in the 6 months before ICU admission 
[at least 0·3 mg/kg per day prednisolone for at least 
1 month], congenital immune-humoral, or cellular 
immune defi ciency state), chemotherapy or radiotherapy 
(in the 6 months before ICU admission), severe mal-
nutrition, and insulin-dependent diabetes mellitus.
Data management and quality control
Detailed instructions explaining the aim of the study, 
instructions for data collection, and defi nitions were 
available through a secured website for all participants 
before starting data collection and throughout the study 
period. Any additional queries were answered on a per-
case basis by the coordinating centre during data 
collection. Validity checks were made concurrent with 
data entry on the electronic CRF including plausibility 
checks within each variable and between variables. Data 
were further reviewed by the coordinating centre for 
plausibility and availability of outcome parameter (death 
in the ICU), and any doubts were clarifi ed with the centre 
in question. There was no on-site monitoring.
Statistical analysis 
Data were processed and analysed in the department of 
intensive care of the University of Brussels, in 
collaboration with the Jena University Hospital (Jena, 
Germany). The appendix includes additional details of 
the statistical analysis.
For the purposes of this study, the world was divided 
into nine geographical regions: North America, South 
America, western Europe, eastern Europe, Middle East, 
south Asia, east and southeast Asia, Oceania, and Africa. 
Individual countries were also classifi ed into three income 
groups in accordance with their 2011 gross national 











Number of patients per centre 10 (5–18) 10 (4–29) 8 (4–13) 11 (5–20)
Severity scores
SAPS II score 40·2 (18·2) 33·4 (17·5)*† 40·7 (18·0) 41·2 (18·1)
APACHE II score 17·9 (9·4) 14·3 (8·9)*† 17·7 (9·4)* 18·7 (9·3)
SOFA score 6·3 (4·2) 4·6 (4·0)*† 6·0 (4·3)* 6·3 (4·4)
Type of admission
Surgical (non-trauma) 3432 (36·0%) 317 (28·2%)*† 926 (39·3%)* 218 (36·2%)
Medical 5382 (56·5%) 728 (64·8%)*† 1216 (51·6%) 3438 (56·9%)
Trauma 643 (6·8%) 71 (6·3%) 189 (8·0%)* 383 (6·3%)
Other 66 (0·7%) 7 (0·6%) 24 (1·0%) 35 (0·6%)
Source of admission
Emergency room or ambulance 3814 (37·9%) 438 (36·2%) 918 (36·7%) 2458 (38·7%)
Hospital fl oor 2625 (26·1%) 221 (18·3%)*† 773 (30·9%)* 1631 (25·7%)
Operating room or recovery room 1811 (18·0%) 147 (12·2%)*† 423 (16·9%)* 1241 (19·5%)
Other hospital 981 (9·7%) 165 (13·6%)*† 242 (9·7%) 574 (9·0%)
Other 838 (8·3%) 238 (19·7%)*† 148 (5·9%) 452 (7·1%)
Comorbidities
COPD 1240 (12·3%) 72 (6·0%)*† 268 (10·7%)* 900 (14·2%)
Cancer (solid, non-metastatic) 888 (8·8%) 73 (6·0%)* 183 (7·3%)* 632 (9·9%)
Diabetes mellitus, insulin-dependent 972 (9·7%) 129 (10·7%) 219 (8·7%) 624 (9·8%)
Heart failure, NYHA III/IV 921 (9·1%) 64 (5·3%)*† 292 (11·7%)* 565 (8·9%)
Chronic renal failure 912 (9·1%) 80 (6·6%)* 188 (7·5%)* 644 (10·1%)
Immunosuppression 757 (7·5%) 63 (5·2%)*† 168 (6·7%) 526 (8·3%)
Cirrhosis 349 (3·5%) 27 (2·2%)* 78 (3·1%) 244 (3·8%)
Metastatic cancer 332 (3·3%) 33 (2·7%) 70 (2·8%) 229 (3·6%)
Haematological cancer 212 (2·1%) 11 (0·9%)* 38 (1·5%)* 163 (2·6%)
HIV infection 71 (0·7%) 3 (0·2%) 24 (1·0%) 44 (0·7%)
Number of comorbidities
None 5512 (54·7%) 784 (64·8%)*† 1396 (55·8%)* 3332 (52·4%)
1 2917 (29·0%) 315 (26·1%) 755 (30·2%) 1847 (29·1%)
2 1252 (12·4%) 92 (7·6%)*† 289 (11·5%)* 871 (13·7%)
3 328 (3·3%) 16 (1·3%)* 61 (2·4%)* 251 (3·9%)
≥4 60 (0·6%) 2 (0·2%) 3 (0·1%) 55 (0·9%)
Infectious status
Infection 2473 (24·6%) 186 (15·4%)*† 706 (28·2%)* 1581 (24·9%)
Sepsis 1808 (18·0%) 120 (9·9%) *† 497 (19·8%) 1191 (18·7%)
Septic shock 986 (9·8%) 60 (5·0%)†* 227 (9·1%)* 699 (11·0%)
Data are median (IQR), mean (SD), or n (%). Valid percentages are given after exclusion of missing values (data missing 
from 546 patients for type of admission). SAPS=simplifi ed acute physiology score. APACHE=acute physiology and chronic 
health evaluation. SOFA=sequential organ failure score. COPD=chronic obstructive pulmonary disease. NYHA=New York 
Heart Association classifi cation. Statistically signifi cant at 5% with Bonferroni correction: *vs high. †vs upper middle.
Table 1: Characteristics of the study cohort on admission to the ICU by GNI stratifi cation 
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World Bank Atlas method:8 GNI less than US$4035 was 
defi ned as low and lower-middle income, $4036–$12 475 
was defi ned as upper-middle income, and greater than 
$12 476 was defi ned as high income (appendix).
Data are summarised with means and SDs, medians 
and IQRs, or numbers and percentages. Crude mortality 
rates are given as percentages with Wald 95% CIs.9 
Single missing values of the SOFA score were imputed 
by linear interpolation. When fi rst or last values were 
missing, the nearest value was carried backward or 
forward, respectively.
The Kolmogorov-Smirnov test was used, and histograms 
and quantile-quantile plots were examined to verify if 
there were signifi cant deviations from the normality 
assumption of continuous variables. Diff erence testing 
between groups was done with ANOVA, Kruskal-Wallis 
test, Student’s t test, Mann-Whitney test, χ² test, or Fisher’s 
exact test, as appropriate. The least signifi cant diff erence 
testing procedure was used for pairwise comparisons.
In-hospital death was analysed using multilevel logistic 
regression with three levels: patient, hospital, and 
country. The results of fi xed eff ects (measures of 
association) are given as odds ratios (OR) with their 
95% CIs and the 80% interval OR.10–12 Random eff ects 
(measures of variation) measures included the variance 
(var) and its SE, the proportional change in variance,12 
and the median OR.10–12 The statistical signifi cance of 
covariates were calculated with the Wald test.13
Data were analysed with IBM SPSS statistics software, 
version 20 for windows, and MLwiN, version 2.28. All 
reported p values are two-sided and a p value of less than 
0·05 was deemed to show statistical signifi cance.
Role of the funding source
There was no funding source for this study. The 
corresponding author had full access to all the data in the 
study and had fi nal responsibility for the decision to 
submit for publication.
Results
10 069 patients were included in the audit, most commonly 
from Europe (5445 patients; 54·1%), Asia (1928; 19·2%), 
and the Americas (1723; 17·1%). Table 1 lists the 
characteristics of the audit cohort on admission to the ICU 
according to GNI. Patients admitted to ICUs in countries 
with lower GNI were less severely ill than those admitted 
in higher income countries; they were more likely to be 
medical patients and less likely to have comorbid COPD or 
heart failure (table 1). Table 2 shows the organisational 
characteristics of the participating centres—most ICUs 
were located in university or academic hospitals. The high-
est hospital bed capacities were in centres from countries 
with higher GNI. There were no other major organisational 
diff erences between the centres according to GNI.
Patients from low-income countries were less likely to 
receive mechanical ventilation or renal replacement 
therapy during the ICU stay than patients in upper-
middle or high income countries (all p<0·0001; table 3).
Almost a third of patients had sepsis during the ICU 
stay, but substantially lower occurrence rates were reported 





Number of countries 84 17 27 40
Type of hospital
University or academic 419 (57·4%) 26 (41·9%)* 148 (62·4%)† 245 (56·8%)
Non-university 247 (33·8%) 27 (43·5%)* 62 (26·2%)† 158 (36·7%)
Unknown 64 (8·8%) 9 (14·5%) 27 (11·4%) 28 (6·5%)
Hospital bed capacity 600 (320–982) 352 (200–600)*† 550 (200–1200) 642 (400–950)
ICU specialty
Surgical 83 (11·4%) 7 (11·3%) 26 (11·0%) 50 (11·6%)
Medical 73 (10·0%) 4 (6·5%) 23 (9·7%) 46 (10·7%)
Mixed 479 (65·6%) 42 (67·7%) 152 (64·1%) 285 (66·1%)
Others 95 (13·0%) 9 (14·5%) 36 (15·2%) 50 (11·6%)
Number of ICU patients, 2011 700 (429–1100) 764 (466–1405) 624 (386–1200) 715 (441–1082)
ICU mortality rate, 2011 14 (8–21) 14 (9–26) 15 (8–22) 13 (8–19)
Number of staff ed ICU beds, on the fi rst day of the study 12 (8–18) 12 (10–20) 14 (10–18)† 12 (8–16)
ICU physician available 24 h/24 h 624 (94·5%) 49 (92·5%) 198 (95·2%) 377 (94·5%)
Physiotherapist available 24 h/24 h 454 (62·2%) 40 (64·5%) 128 (54%)† 286 (66·4%)
Pharmacist available 24 h/24 h 276 (37·8%) 23 (37·1%) 84 (35·4%) 169 (39·2%)
Technician available 24 h/24 h 286 (39·2%) 35 (56·5%)† 105 (44·3%)† 146 (33·9%)
Data are n (%) or median (IQR). Valid percentages are displayed after exclusion of missing values (data missing from 70 centres for ICU physician availability, 81 centres for 
number of ICU patients [2011], 89 centres for 2011 ICU mortality rates, 68 centres for number of staff ed ICU beds, and 105 centres for hospital bed capacity). GNI=gross 
national income. ICU=intensive care unit. Statistically signifi cant at 5% with Bonferroni correction: *vs upper middle. †vs high.
Table 2: Characteristics of the participating centres by GNI
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in south Asia and the highest rates were reported in east 
and southeast Asia and the Middle East (table 3). Of the 
patients with sepsis, 1808 (60·8%) already had sepsis on 
admission to the ICU, and 1681 (56·5%) had septic shock.
ICU and hospital mortality rates varied widely by 
geographical region (table 3). Crude ICU and hospital 
mortality rates were higher in patients admitted to ICUs 
in upper-middle income countries than to ICUs in low 
and lower-middle or high-income countries (all 
p<0·0001). The highest crude ICU and hospital mortality 
rates were recorded in patients admitted to ICUs in 
countries with upper-middle GNI (table 3). Hospital 
mortality rates per country according to GNI are shown 
in the appendix.
ICU and hospital mortality rates in patients with sepsis 
were 25·8% (24·2–27·4) and 35·3% (33·5–37·1), 
respectively, and varied between 11·9% and 19·3% 
(Oceania) to 39·5% and 47·2% (Africa), respectively.
The unconditional model suggested signifi cant between-
country variations (var=0·19, p=0·002) and between-
hospital variations (var=0·43, p<0·0001) in the individual 
risk of in-hospital death (appendix). Between-hospital 
variations seemed to be greater than between-country 
variations, as shown by the median OR (1·86 vs 1·51).
After controlling for patient and hospital factors and 
GNI (country factor), the diff erences across hospitals 
decreased by 49% but remained signifi cant (var=0·34, 
p<0·0001); by contrast, the diff erences across countries 
disappeared after adjustment (82% decrease, var=0·03, 
p=0·18). There was a stepwise increase in the adjusted risk 
of in-hospital death with decreasing GNI (fi gure, appendix) 
such that, compared with patients from high income 
countries, those from upper-middle income countries 
(OR 1·74, 95% CI 1·38–2·20) and low and lower-middle 
income countries (OR 2·10, 1·46–3·03) had a greater risk 
of in-hospital death.
Patients with sepsis were more at risk of in-hospital 
death than those without (OR 1·29, 1·13–1·48). Other 
independent risk factors for in-hospital death included 
older age, higher SAPS II score, medical or trauma 
admission (compared with the surgical admission group), 
admissions from the hospital fl oor (compared with 
admissions from the emergency room or ambulance), 
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ICU=intensive care unit. SAPS=simplifi ed acute physiology score. APACHE=acute physiology and chronic health evaluation. RRT=renal replacement therapy. GNI=gross national income.
Table 3: Epidemiology, major ICU interventions and sepsis occurrence on admission or during ICU stay, and mortality rates 
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immunosuppression, cirrhosis, and the need for mecha-
nical ventilation or renal replacement therapy (appendix).
Discussion
Our study shows important aspects related to the burden 
of intensive care worldwide. Notably, after adjustment for 
possible confounders in a multivariable analysis, there 
was a stepwise increase in the risk of in-hospital death 
according to decreasing GNI. There are many possible 
reasons for this fi nding, including potential issues 
related to diff erences in availability of trained staff  and 
treatments or in quality of care. There are few data 
available concerning intensive care facilities in lower 
income countries (panel).14 A recent study from Tanzania 
reported that although suffi  cient equipment and drugs 
seemed to be available for emergency and critical care, 
the infrastructure, training, and process of care were 
inadequate.16 Similar fi ndings have been reported from 
other low income countries.17–20
Using multilevel modelling to assess the reasons 
involved in the individual risk of in-hospital death, our 
fi ndings suggest that the centre eff ect might be more 
important than the eff ect of GNI, suggesting that 
diff erences in ICU organisation among centres within any 
one country have a key role in determining patient 
outcomes. Various organisational issues have been shown 
to aff ect ICU patient outcomes in diff erent countries.21–23 In 
a study of 24 ICUs in one US county,24 patients with acute 
lung injury had better outcomes if cared for in a closed-
format (units that transferred all patients to an intensive 
care team or where a consultation with an intensivist who 
then shared responsibility for patient management with 
the admitting physician was mandatory) than in an open-
format (units where any attending physician with ICU 
admitting privileges could be responsible for patient 
management) ICU. In a recent study of 69 ICUs across the 
USA,23 daily care review and a lower bed-to-nurse ratio 
were associated with a lower annual ICU mortality, but not 
closed ICU format or 24-h presence of an intensivist. In an 
analysis of the large EPIC II database, a high nurse-to-
patient ratio was noted to be independently associated with 
a lower risk of in-hospital death (Sakr Y, unpublished). 
Availability of a consultant-level intensivist and use of 
multidisciplinary clinical wardrounds are known to be 
associated with a high level of quality of care.25 The eff ect of 
ICU infrastructure, staff  training and availability, and 
process of care on patient outcomes clearly needs further 
study so that intensive care provision can be optimised 
across centres and resources can be targeted most 
appropriately on a global basis.
Our study has several limitations that should be 
considered when interpreting the data. First, although 
the audit included many ICUs, the voluntary nature of 
the participation might have aff ected the number and 
types of centres participating, perhaps particularly in the 
low and lower-middle income countries. This might have 
led to an underestimation of the burden of critical illness 
in these areas. Moreover, we are unable to assess how 
representative the participating hospitals are of their 
region. For example, a high percentage of the ICUs from 
low and lower-middle income countries reported 24-h 
intensivist cover and many reported high availability of 
ancillary staff , which seems to confl ict with some other 
reports from these countries.14 Some patient 
characteristics also seem to confl ict with other data from 
these regions—eg, the rate of HIV infection was lowest 
in the low and lower-middle income countries, although 
in general the prevalence of HIV in these countries, 
many of which are located in sub-Saharan Africa, is 
particularly high.14 The reasons for these apparent 
diff erences are not clear but probably relate to, at least 
partly, some degree of sample bias. The lower prevalence 
of reported comorbidities (COPD and heart failure) in 
low and lower-middle income countries versus high 
income countries might have been related to reporting 
bias. With the likely lower access to medical facilities in 
low and lower-income countries, it is possible that 
patients are less likely to have been diagnosed with a 
chronic disease. Nonetheless, our cohort provides large-
scale comparative data in critically ill patients across 
multiple geographical areas and should be regarded as a 
unique initiative that can encourage future international 
collaboration in this fi eld.
Second, data collection was not monitored and only 
incongruous data were verifi ed. Third, missing SOFA 
scores were imputed by linear interpolation or carrying 
values backward or forward, which might potentially 
aff ect our estimations; however, the percentage of imputed 
data was small (about 3%) so it is unlikely that this will 
have had a major infl uence. Fourth, we analysed countries 
according to GNI, rather than the percentage of GDP 
allocated to health care specifi cally, but these data are 
diffi  cult to obtain and less comparable because their 
Figure: Adjusted odds ratios of in-hospital death
Odds ratios are according to the GNI in the whole cohort, with patients admitted to 
intensive care units in countries with high GNI as the reference category. Model 2 
includes adjustment for hospital-level variables. Model 3 includes adjustment for 
patient-level and hospital-level variables. GNI=gross national income. 
Model 2
Model 3
Low and lower middle
Upper middle
High
Odds ratio  (95% CI)
GN
I
0 1 2 3
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defi nition varies among countries. Fifth, because of the 
study design, data were collected over a short period of 
time and it is possible that this period was not 
representative of the average annual situation in each 
centre. Finally, the results of the multilevel analysis might 
not have accounted for unmeasured variables, but we 
adjusted for a large number of variables that might aff ect 
outcome.
The frequency of sepsis in our cohort was similar to that 
reported in the SOAP study (37·4%).26 Other studies27–29 
have reported lower incidences of sepsis, but our study 
did not include routine postoperative patients.
Although study entry was entirely voluntary, the large 
amount of data collected on more than 10 000 patients 
from more than 80 countries shows the perceived need for 
such an international audit. International epidemiological 
data such as these provide a valuable insight into the global 
burden of critical illness worldwide. Indeed, several recent 
reports have highlighted the lack of information on the 
global burden of critical illness and availability of intensive 
care and called for studies to broaden knowledge in this 
fi eld.2,14,15 The results of the present audit, bearing in mind 
the limitations of the study design as discussed, show a 
strong relation between the risk of death and the GNI, and 
suggest that diff erences in ICU organisation among 
centres might have an important role in determining risk 
of death, although our data are insuffi  cient to capture 
which specifi c aspects might be involved. Further study is 
needed to better defi ne those aspects of ICU organisation 
that have the greatest eff ect.
Our data also show that sepsis remains a major health 
problem worldwide, associated with high mortality rates 
Panel: Research in context
Systematic review
We searched PubMed for reports published before Dec 1, 
2013, with the search terms “critical illness”, “intensive care 
medicine”, “burden”, “outcome”, and “global”. The search was 
limited to reports in English. We also checked the reference 
lists of reports identifi ed in the search. Global comparative 
cohorts investigating intensive care practice, outcome, and 
the burden of critical illness are lacking. Several recent papers 
have highlighted the lack of information on the global 
burden of critical illness and availability of intensive care and 
called for studies to broaden knowledge in this fi eld.2,14,15
Interpretation
To our knowledge, our study provides the largest available 
report of information related to provision of intensive care 
worldwide. The results of the present audit show a strong 
relation between the risk of death and the global national 
income, and suggest that diff erences in ICU organisation 
among centres play an important part in determining risk of 
death. Our data also show that sepsis remains a major health 
problem worldwide, associated with high mortality rates in 
all countries.
in all countries, supporting the need for continued 
emphasis to be placed on the epidemiology, prevention, 
and treatment of this important societal problem.
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